PRELUDE CORP

Profile

Company Names

PRELUDE CORP

Addresses

26051 MERIT CIRCLE, SUITE 103, LAGUNA HILLS, CA 92563

26051 MERIT CIRCLE, SUITE 102, LAGUNA HILLS, CA 92653

Phone Numbers

(949) 348-1188

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$40,931,163.00

Number of Funding Rounds:

6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2025-10-30 
$5,000,000.00 
$7,500,000.00 
$2,500,000.00 
Debt 
5
2022-01-31 
$9,281,159.00 
$20,000,001.00 
$10,718,842.00 
Equity 
4
2019-12-27 
$10,000,013.00 
$10,000,013.00 
$0.00 
Equity 
3
2018-07-20 
$8,999,991.00 
$8,999,991.00 
$0.00 
Equity 
2
2017-02-28 
$5,499,998.00 
$5,499,998.00 
$0.00 
Equity 
1
2016-02-26 
$2,150,002.00 
$3,000,000.00 
$849,998.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
GERRIT 
 
ADAMS 
DIRECTOR
RELIGN CORP   |  SOLACE THERAPEUTICS INC   |  PRELUDE CORP   |  DXTX PAIN + SPINE LLC
OLAV 
B. 
BERGHEIM 
EXECUTIVE OFFICER, DIRECTOR
DENTATEK CORP   |  CARDIOPOLYMERS, INC.   |  ARGES IMAGING INC.   |  METRONOM HEALTH, INC.   |  GLAUKOS CORP   |  SONENDO, INC.   |  LONESTAR HEART, INC.   |  ADAGIO MEDICAL, INC.   |  ANAXIOM CORP   |  PRELUDE CORP   |  OTELLO MEDICAL, INC.   |  YAP THERAPEUTICS INC
DANIEL 
 
FORCHE 
EXECUTIVE OFFICER, DIRECTOR
PRELUDE CORP
WILLIAM 
 
LINK 
DIRECTOR
NEOVISTA INC   |  LENSX LASERS INC   |  DOSE MEDICAL CORP   |  SECOND SIGHT MEDICAL PRODUCTS INC   |  OCULEVE, INC.   |  VERSANT VENTURE CAPITAL V, L.P.   |  VERSANT AFFILIATES FUND V, L.P.   |  VERSANT OPHTHALMIC AFFILIATES I, L.P.   |  VERSANT VENTURE CAPITAL V (CANADA), LP   |  ALPHAEON CORP   |  ONEFOCUS VISION, INC.   |  PRELUDE CORP   |  VERSANT VENTURE V AIV FEEDER HOLDINGS, L.P.   |  VERSANT VENTURE V AIV, L.P.   |  SIGHTLIFE SURGICAL, INC.   |  RXSIGHT, INC.   |  TEARCLEAR CORP.   |  EYEBRAIN MEDICAL, INC.   |  CORNEAGEN INC.   |  ALLEGRO OPHTHALMICS, LLC   |  VIALASE, INC.   |  EQUINOX OPHTHALMIC, INC.   |  NEUROLENS, INC.
WILLIAM 
J. 
LINK 
DIRECTOR
ORAMETRIX INC   |  INOGEN INC   |  GLAUKOS CORP   |  CAMERON HEALTH, INC.   |  VERSANT AFFILIATES FUND I-B LP   |  VERSANT AFFILIATES FUND I-A LP   |  VERSANT SIDE FUND I LP   |  VERSANT SIDE FUND II, LP   |  ACUFOCUS, INC.   |  EDWARDS LIFESCIENCES CORP   |  PRELUDE CORP   |  ALLEGRO OPHTHALMICS, LLC   |  LENSAR, INC.
DEREK 
 
MAETZOLD 
DIRECTOR
CASTLE BIOSCIENCES INC   |  ASSURANCE BIOSCIENCES, INC.   |  PRELUDE CORP
HUGH 
 
NEUHARTH 
DIRECTOR, EXECUTIVE OFFICER
FJORD CAPITAL PARTNERS I, L.P.   |  ARGES IMAGING INC.   |  METRONOM HEALTH, INC.   |  CIANNA MEDICAL INC   |  LONESTAR HEART, INC.   |  ADAGIO MEDICAL, INC.   |  SONENDO, INC.   |  ANAXIOM CORP   |  PRELUDE CORP   |  KATO PHARMACEUTICALS, INC.
ALEJANDRO 
 
SANCHEZ 
DIRECTOR
KNOME INC   |  TRYTON MEDICAL INC   |  BIOTHERANOSTICS, INC.   |  ENDOGASTRIC SOLUTIONS INC   |  PRELUDE CORP
ANDREW 
 
WADE 
EXECUTIVE OFFICER
PRELUDE CORP   |  ADAGIO MEDICAL, INC.   |  YAP THERAPEUTICS INC   |  ANAXIOM CORP
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-11-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2025-10-30 
2022-02-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-01-31 
2020-01-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-12-27 
2018-07-27
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-07-20 
2017-03-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-02-28 
2016-03-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-02-26 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#